Like a skittish driver slamming the brakes, a special class of T cells may be limiting the effectiveness of therapeutic vaccines for HIV by slowing the immune system response too soon, report health science researchers. Their study may help researchers improve the efficacy of such vaccines by devising methods to circumvent the braking mechanism of these cells.